{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T20:32:40Z","timestamp":1785184360663,"version":"3.55.0"},"reference-count":48,"publisher":"The Endocrine Society","issue":"4","license":[{"start":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T00:00:00Z","timestamp":1767398400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"U.S. Department of Veterans Affairs Health Services Research and Development Service Merit Review Award","award":["I01HX003952-01A1"],"award-info":[{"award-number":["I01HX003952-01A1"]}]},{"name":"National Institute of Aging of the National Institutes of Health","award":["R01 AG079833"],"award-info":[{"award-number":["R01 AG079833"]}]},{"name":"National Institutes of Health, the U.S. Department of Veterans Affairs, or the U.S. Government"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>There is widespread and increasing thyroid hormone overuse. Levothyroxine, a synthetic form of thyroid hormone, is one of the most prescribed medications in the United States. Many patients are started on levothyroxine for the treatment of mild subclinical hypothyroidism or nonevidence-based indications (eg, euthyroid individuals with weight gain or depression). High-certainty evidence does not show a benefit of thyroid hormone initiation in important patient outcomes (eg, quality of life, hypothyroid symptoms) for patients with subclinical hypothyroidism. Moreover, thyroid hormone treatment is associated with potential patient burden, harms, and costs. Yet, once levothyroxine is initiated, it is continued lifelong for most patients. Therefore, active interventions are needed to reduce unnecessary thyroid hormone treatment when it is clinically appropriate. Deprescribing is a structured and evidence-based approach to safely taper or discontinue unnecessary or potentially inappropriate medications, aiming to reduce polypharmacy, improve outcomes, and decrease health care costs and patient harm. Recent limited data support the feasibility and safety of thyroid hormone deprescribing in selected patients and describe clinician-, patient-, and system-level barriers and facilitators to implementing this intervention. We present 3 illustrative clinical cases of patients taking levothyroxine to exemplify the rationale and key considerations in thyroid hormone deprescribing, emphasizing that a structured, patient-centered, and closely supervised plan is essential for safe and effective thyroid hormone deescalation in clinically appropriate situations.<\/jats:p>","DOI":"10.1210\/clinem\/dgaf697","type":"journal-article","created":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T12:44:02Z","timestamp":1766839442000},"page":"1169-1174","source":"Crossref","is-referenced-by-count":5,"title":["Approach to the Patient Considering Thyroid Hormone Deprescribing"],"prefix":"10.1210","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7259-132X","authenticated-orcid":false,"given":"Spyridoula","family":"Maraka","sequence":"first","affiliation":[{"name":"Division of Endocrinology and Metabolism, University of Arkansas for Medical Sciences and Central Arkansas Veterans Healthcare System , Little Rock, AR 72205 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2276-0046","authenticated-orcid":false,"given":"Maria","family":"Papaleontiou","sequence":"additional","affiliation":[{"name":"Division of Metabolism, Endocrinology and Diabetes, and Institute of Gerontology, University of Michigan , Ann Arbor, MI 48109 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2026,1,3]]},"reference":[{"issue":"6","key":"2026031619574922000_dgaf697-B1","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1210\/jc.2018-02197","article-title":"Generic and brand-name thyroid hormone drug use among commercially insured and medicare beneficiaries, 2007 through 2016","volume":"104","author":"Ross","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"17","key":"2026031619574922000_dgaf697-B2","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1001\/jama.2015.13766","article-title":"Trends in prescription drug use among adults in the United States from 1999-2012","volume":"314","author":"Kantor","year":"2015","journal-title":"JAMA"},{"issue":"2","key":"2026031619574922000_dgaf697-B3","first-page":"43","article-title":"Comprehension of top 200 prescribed drugs in the US as a resource for pharmacy teaching, training and practice","volume":"6","author":"Fuentes","year":"2018","journal-title":"Pharmacy (Basel)"},{"issue":"10","key":"2026031619574922000_dgaf697-B4","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1001\/jamainternmed.2021.2686","article-title":"Levothyroxine use in the United States, 2008-2018","volume":"181","author":"Brito","year":"2021","journal-title":"JAMA Intern Med"},{"issue":"2","key":"2026031619574922000_dgaf697-B5","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3122\/jabfm.2020.02.190159","article-title":"Thyroid hormone use in the United States, 1997-2016","volume":"33","author":"Johansen","year":"2020","journal-title":"J Am Board Fam Med"},{"issue":"8","key":"2026031619574922000_dgaf697-B6","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1089\/thy.2019.0402","article-title":"Levothyroxine replacement therapy and overuse: a timely diagnostic approach","volume":"29","author":"Livadas","year":"2019","journal-title":"Thyroid"},{"key":"2026031619574922000_dgaf697-B7"},{"issue":"19","key":"2026031619574922000_dgaf697-B8","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1001\/jama.2025.13559","article-title":"Hypothyroidism: a review","volume":"334","author":"Chaker","year":"2025","journal-title":"JAMA"},{"issue":"2","key":"2026031619574922000_dgaf697-B9","doi-asserted-by":"crossref","first-page":"e765","DOI":"10.1210\/clinem\/dgad517","article-title":"Appropriateness of levothyroxine prescription: a multicenter retrospective study","volume":"109","author":"Ayala","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2026031619574922000_dgaf697-B10","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.4158\/1934-2403-22.11.1358","article-title":"Inappropriate use of suppressive doses of thyroid hormone in thyroid nodule management: results from a nationwide survey","volume":"22","author":"Papaleontiou","year":"2016","journal-title":"Endocr Pract"},{"issue":"5","key":"2026031619574922000_dgaf697-B11","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/MED.0000000000000758","article-title":"Towards De-Implementation of low-value thyroid care in older adults","volume":"29","author":"Perkins","year":"2022","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"5","key":"2026031619574922000_dgaf697-B12","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1089\/thy.2020.0679","article-title":"Clinical outcomes after discontinuation of thyroid hormone replacement: a systematic review and meta-analysis","volume":"31","author":"Burgos","year":"2021","journal-title":"Thyroid"},{"issue":"3","key":"2026031619574922000_dgaf697-B13","doi-asserted-by":"crossref","first-page":"201","DOI":"10.4212\/cjhp.v66i3.1261","article-title":"Deprescribing: what is it and what does the evidence tell us?","volume":"66","author":"Thompson","year":"2013","journal-title":"Can J Hosp Pharm"},{"issue":"8","key":"2026031619574922000_dgaf697-B14","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1001\/jamainternmed.2023.2099","article-title":"What should I know about medication deprescribing?","volume":"183","author":"Wu","year":"2023","journal-title":"JAMA Intern Med"},{"key":"2026031619574922000_dgaf697-B15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejim.2016.12.021","article-title":"Deprescribing: a narrative review of the evidence and practical recommendations for recognizing opportunities and taking action","volume":"38","author":"Reeve","year":"2017","journal-title":"Eur J Intern Med"},{"issue":"6","key":"2026031619574922000_dgaf697-B16","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.sapharm.2018.08.013","article-title":"Deprescribing: future directions for research","volume":"15","author":"Thompson","year":"2019","journal-title":"Res Social Adm Pharm"},{"issue":"6","key":"2026031619574922000_dgaf697-B17","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/bcp.12732","article-title":"A systematic review of the emerging de fi nition of \u2018deprescribing\u2019 with network analysis: implications for future research and clinical practice","volume":"80","author":"Reeve","year":"2015","journal-title":"Br J Clin Pharmacol"},{"issue":"15","key":"2026031619574922000_dgaf697-B18","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1001\/jama.2016.9534","article-title":"Thyroid-stimulating hormone in the evaluation of subclinical hypothyroidism","volume":"316","author":"Papaleontiou","year":"2016","journal-title":"JAMA"},{"issue":"4","key":"2026031619574922000_dgaf697-B19","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1210\/jc.2008-1696","article-title":"High frequency of and factors associated with thyroid hormone over-replacement and under-replacement in men and women aged 65 and over","volume":"94","author":"Somwaru","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2026031619574922000_dgaf697-B20","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1007\/s40618-025-02543-2","article-title":"Thyroxine overuse and clinical indices guiding successful treatment withdrawal","volume":"48","author":"Livadas","year":"2025","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"2026031619574922000_dgaf697-B21","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1001\/jamainternmed.2013.11312","article-title":"Falling threshold for treatment of borderline elevated thyrotropin levels-balancing benefits and risks: evidence from a large community-based study","volume":"174","author":"Taylor","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"12","key":"2026031619574922000_dgaf697-B22","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1089\/thy.2014.0028","article-title":"Guidelines for the treatment of hypothyroidism: prepared by the American thyroid association task force on thyroid hormone replacement","volume":"24","author":"Jonklaas","year":"2014","journal-title":"Thyroid"},{"issue":"12","key":"2026031619574922000_dgaf697-B23","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1089\/thy.2012.0205","article-title":"Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association","volume":"22","author":"Garber","year":"2012","journal-title":"Thyroid"},{"key":"2026031619574922000_dgaf697-B24","doi-asserted-by":"crossref","first-page":"l2006","DOI":"10.1136\/bmj.l2006","article-title":"Thyroid hormones treatment for subclinical hypothyroidism: a clinical practice guideline","volume":"365","author":"Bekkering","year":"2019","journal-title":"BMJ"},{"issue":"2","key":"2026031619574922000_dgaf697-B25","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S2213-8587(21)00285-0","article-title":"Subclinical hypothyroidism in older individuals","volume":"10","author":"Biondi","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"2026031619574922000_dgaf697-B26","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1210\/endrev\/bnab031","article-title":"Optimal thyroid hormone replacement","volume":"43","author":"Jonklaas","year":"2022","journal-title":"Endocr Rev"},{"issue":"14","key":"2026031619574922000_dgaf697-B27","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1001\/archinte.167.14.1533","article-title":"Serum thyrotropin measurements in the community: five-year follow-up in a large network of primary care physicians","volume":"167","author":"Meyerovitch","year":"2007","journal-title":"Arch Intern Med"},{"issue":"13","key":"2026031619574922000_dgaf697-B28","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.2018.13770","article-title":"Association of thyroid hormone therapy with quality of life and thyroid-related symptoms in patients with subclinical hypothyroidism: a systematic review and meta-analysis","volume":"320","author":"Feller","year":"2018","journal-title":"JAMA"},{"issue":"1","key":"2026031619574922000_dgaf697-B29","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s40261-016-0462-3","article-title":"The economic impact of levothyroxine dose adjustments: the CONTROL HE study","volume":"37","author":"Ernst","year":"2017","journal-title":"Clin Drug Investig"},{"issue":"4","key":"2026031619574922000_dgaf697-B30","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1089\/thy.2020.0629","article-title":"Knowledge, attitudes, beliefs, and treatment burden related to the use of levothyroxine in hypothyroid pregnant women in the United States","volume":"31","author":"Toloza","year":"2021","journal-title":"Thyroid"},{"issue":"9","key":"2026031619574922000_dgaf697-B31","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1089\/thy.2015.0180","article-title":"Thyroid hormone therapy and risk of thyrotoxicosis in community-resident older adults: findings from the baltimore longitudinal study of aging","volume":"25","author":"Mammen","year":"2015","journal-title":"Thyroid"},{"issue":"19","key":"2026031619574922000_dgaf697-B32","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1056\/NEJM199411103311901","article-title":"Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons","volume":"331","author":"Sawin","year":"1994","journal-title":"N Engl J Med"},{"issue":"10","key":"2026031619574922000_dgaf697-B33","doi-asserted-by":"crossref","first-page":"e3890","DOI":"10.1210\/clinem\/dgab444","article-title":"Thyroid hormone therapy and incident stroke","volume":"106","author":"Papaleontiou","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2026031619574922000_dgaf697-B34","doi-asserted-by":"crossref","first-page":"e2211863","DOI":"10.1001\/jamanetworkopen.2022.11863","article-title":"Association of thyroid hormone treatment intensity with cardiovascular mortality among US veterans","volume":"5","author":"Evron","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"1","key":"2026031619574922000_dgaf697-B35","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1210\/jc.2009-1625","article-title":"Serum thyroid-stimulating hormone concentration and morbidity from cardiovascular disease and fractures in patients on long-term thyroxine therapy","volume":"95","author":"Flynn","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2026031619574922000_dgaf697-B36","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1089\/thy.2017.0517","article-title":"Over- and under-treatment of hypothyroidism is associated with excess mortality: a register-based cohort study","volume":"28","author":"Lillevang-Johansen","year":"2018","journal-title":"Thyroid"},{"key":"2026031619574922000_dgaf697-B37","doi-asserted-by":"crossref","first-page":"l4892","DOI":"10.1136\/bmj.l4892","article-title":"Thyroid replacement therapy, thyroid stimulating hormone concentrations, and long term health outcomes in patients with hypothyroidism: longitudinal study","volume":"366","author":"Thayakaran","year":"2019","journal-title":"BMJ"},{"issue":"2","key":"2026031619574922000_dgaf697-B38","doi-asserted-by":"crossref","first-page":"e2148599","DOI":"10.1001\/jamanetworkopen.2021.48599","article-title":"Development of a metric to detect and decrease low-value prescribing in older adults","volume":"5","author":"Radomski","year":"2022","journal-title":"JAMA Netw Open"},{"key":"2026031619574922000_dgaf697-B39","author":"McCarthy"},{"issue":"2","key":"2026031619574922000_dgaf697-B40","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s12020-025-04371-z","article-title":"Discontinuation of levothyroxine therapy in patients with subclinical hypothyroidism: a pilot randomized clinical trial","volume":"90","author":"Maraka","year":"2025","journal-title":"Endocrine"},{"issue":"5","key":"2026031619574922000_dgaf697-B41","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1001\/jamainternmed.2015.0324","article-title":"Reducing inappropriate polypharmacy: the process of deprescribing","volume":"175","author":"Scott","year":"2015","journal-title":"JAMA Intern Med"},{"issue":"18","key":"2026031619574922000_dgaf697-B42","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1001\/jama.2018.16131","article-title":"Effect of a pharmacist-led educational intervention on inappropriate medication prescriptions in older adults: the D-PRESCRIBE randomized clinical trial","volume":"320","author":"Martin","year":"2018","journal-title":"JAMA"},{"issue":"1","key":"2026031619574922000_dgaf697-B43","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1186\/s13063-019-3728-2","article-title":"Reduction of the long-term use of proton pump inhibitors by a patient-oriented electronic decision support tool (arriba-PPI): study protocol for a randomized controlled trial","volume":"20","author":"Rieckert","year":"2019","journal-title":"Trials"},{"issue":"4","key":"2026031619574922000_dgaf697-B44","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1136\/eb-2012-100930","article-title":"Deciding when to stop: towards evidence-based deprescribing of drugs in older populations","volume":"18","author":"Scott","year":"2013","journal-title":"Evid Based Med"},{"issue":"7","key":"2026031619574922000_dgaf697-B45","doi-asserted-by":"crossref","first-page":"390","DOI":"10.5694\/mja14.00146","article-title":"First do no harm: a real need to deprescribe in older patients","volume":"201","author":"Scott","year":"2014","journal-title":"Med J Aust"},{"issue":"1","key":"2026031619574922000_dgaf697-B46","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/s13063-015-0791-1","article-title":"A consumer-targeted, pharmacist-led, educational intervention to reduce inappropriate medication use in community older adults (D-PRESCRIBE trial): study protocol for a cluster randomized controlled trial","volume":"16","author":"Martin","year":"2015","journal-title":"Trials"},{"issue":"6","key":"2026031619574922000_dgaf697-B47","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1001\/jamainternmed.2014.949","article-title":"Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: the EMPOWER cluster randomized trial","volume":"174","author":"Tannenbaum","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"2","key":"2026031619574922000_dgaf697-B48","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/jgs.19219","article-title":"Physician-reported barriers and facilitators to thyroid hormone deprescribing in older adults","volume":"73","author":"Moretti","year":"2025","journal-title":"J Am Geriatr Soc"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgaf697\/66213269\/dgaf697.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/4\/1169\/66213269\/dgaf697.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/4\/1169\/66213269\/dgaf697.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T23:58:04Z","timestamp":1773705484000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/111\/4\/1169\/8409708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,3]]},"references-count":48,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,1,3]]},"published-print":{"date-parts":[[2026,3,17]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgaf697","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4]]},"published":{"date-parts":[[2026,1,3]]}}}